Cargando…
Predicting immune checkpoint inhibitor response in urothelial carcinoma: another step in personalised medicine?
Prediction of treatment response is a crucial issue in individualised treatment for cancer patients. In this context, Nassar and colleagues in the accompanying study published in the British Journal of Cancer analysed retrospectively a cohort of 62 metastatic urothelial cancer patients treated with...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029037/ https://www.ncbi.nlm.nih.gov/pubmed/31857721 http://dx.doi.org/10.1038/s41416-019-0684-2 |